EURAX CREAM DERM 20G 10%

EURAX 10% CREMA

active ingredients

100 g cream contain - Active ingredient: chrotamitone 10 g. Excipients with known effect: cetostearilic alcohol, propylene glycol. For the full list of excipients, see paragraph 6.1

Excellent

Glicerol monostearate 40-55; propylene glycol; isopropyl mixed; polyoxyl 40 stearate; cetostearilic alcohol; liquid paraffin; purified water.

Therapeutic indications

Banal pruritis without obvious skin modifications: anal itching, vulvary; insect bites, hives, itchings of allergic origin. In case of infestation of the skin due to the scabies, the preparation can be used as an acaricida.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. All recent dermatosis accompanied by irritation, excision and, generally, skin affections requiring wet treatment (wets).

Population

For skin use. Prudence : Eurax should be applied 2-3 times a day in the itching areas by slightly frying. Eurax is a cream that penetrates easily into the skin, not untight and that does not stain the linen. The treatment must be carried out until itching is disappeared, even in refractory cases requiring prolonged treatment, since Eurax is well tolerated. If itching persists after 5 days of treatment, it is recommended to consult your doctor. It's scratchy : After a warm and dry skin bath, apply Eurax on the entire body surface, except for the face and scalp, slightly frying, 1 time a day, preferably in the evening. The cream should be applied especially in the areas of acereal predilection: interdigital spaces, wrists, armpits, genital organs. The treatment should be continued for a period of 3-5 days depending on the therapeutic result. Change the bed linen and underwear. After completion of treatment, you have to take a bath to wash the body. In children under 3 years of age, such as antifog, Eurax must be used with caution and only under medical control.

Conservation

Do not store at temperature above 30°C.

Warnings

• Eurax cream is only for external use. • Eurax should not be used on the oral mucosa or around the eyes since contact with eyelids can give rise to joint inflammation. In case of accidental contact with the eyes or with the oral mucosa rinse thoroughly with running water. • Eurax should not be applied in the presence of wounds with exudate, acute eczema, lacerated skin, or very inflamed skin. In the presence of eczematous scabies, the eczema should be treated before the scabies. • Important information about some excipients: - this medicine contains propylene glycol which can cause skin irritation; - this medicine contains cetosteari alcohol which can cause local skin reactions (e.g. contact dermatitis).

Interactions

No interaction studies have been carried out.

Effects

Summary of the security profile. The most commonly reported adverse reaction during treatment is itching. Rarely, contact dermatitis and hypersensitivity reactions such as rash, eczema, erythema, skin irritation and angioedema may appear. Tabulate list of adverse reactions. Adverse reactions are listed below by classification for organ and frequency systems. The frequencies are definitive as: very common (≥ 1/10), common (≥ 1/100 to Pathologies of the skin and subcutaneous tissue. Not common: itching; Rare: contact dermatitis, hypersensitivity (such as rash, eczema, erythema, skin irritation, angioedema). Treatment should be stopped if severe irritation occurs. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

Synonyms In case of accidental ingestion, symptoms of acute intoxication such as nausea, vomiting and irritation of the oral mucosa, esophagus and gastric mucosa can be observed. Rare cases of loss of consciousness and convulsioni.Devono general measures should be taken to eliminate the drug and to reduce its absorption The symptomatic treatment should be administered as appropriate. Although very rare, in case of accidental ingestion, as well as in case of excessive skin absorption, there is the risk of metaemoglobinemia. A case of percutaneous overdose of chrotamitone (Eurax cream) and suspicion of metaemoglobinemia after extensive use in a two and a half months child. Management Symptoms usually disappear after the suspension of the drug, but in more serious cases you can consider the treatment with methylene blue.

Pregnancy: No controlled studies are available with the use of Eurax during pregnancy. Therefore, Eurax is not recommended during pregnancy, especially in the first three months. Nursing: It is not known whether the active ingredient (crotamitone) of Eurax is excreted in breast milk after topical application. Therefore, mothers should not use Eurax during breastfeeding if not indicated by a doctor. Fertility: Data on the potential effects of chrotamitone on fertility are not available.

Source: Farmadati